Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid aptamer targeting cell surface antigen mfi2 protein and its application

A nucleic acid aptamer and surface antigen technology, which can be used in medical preparations, anti-tumor drugs, and pharmaceutical formulations with non-active ingredients, which can solve problems such as high price and life-threatening

Active Publication Date: 2021-07-02
ZHEJIANG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But at the same time, there are still many deficiencies in antibody drugs, high prices, and life-threatening immunogenicity caused by antibody macromolecules in the body, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid aptamer targeting cell surface antigen mfi2 protein and its application
  • Nucleic acid aptamer targeting cell surface antigen mfi2 protein and its application
  • Nucleic acid aptamer targeting cell surface antigen mfi2 protein and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Example 1: Affinity of aptamer MS2-1 to MFI2+ / +Panc-1 cells.

[0014] 293T and Panc-1 cells were washed twice with binding buffer, digested with EDTA and prepared into single cell suspension. After counting, add 500,000 / group to a centrifuge tube and resuspend in binding buffer. Add 250nM DNA to each tube and make up to 100μl with binding buffer. Incubate at 37°C in the dark for 30 min, centrifuge to remove the supernatant, and wash twice with binding buffer. Add 500μl binding buffer, mix well, and detect by flow cytometry.

[0015] The affinity curve was detected and drawn by flow cytometry, and the calculated Kd value was 39nM, indicating that the nucleic acid aptamer MS2-1 has a good affinity with Panc-1 cells, see figure 1 .

Embodiment 2

[0016] Example 2: Endocytosis of aptamer MS2-1 in MFI2 positive cells and MFI2 negative cells.

[0017] The small discs seeded with 293T and Panc-1 cells in advance were clamped out from the 6-well plate, fixed with 4% paraformaldehyde for 30 min, and washed twice with binding buffer. Configure 250nM MS2 aptamer solution with binding buffer, add 50ul dropwise to each small disc, and incubate at 4°C and 37°C in the dark for 0.5h, 1h, and 3h, respectively. Wash 3 times with binding buffer, add DAPI to mount.

[0018] The results showed that the nucleic acid aptamer MS2-1 could bind to the membrane surface of MFI2+ / +Panc-1 cells after incubation for 3 hours at 4°C, but could not be endocytosed by the cells. At 37°C, the nucleic acid aptamer MS2-1 began to be endocytosed by Panc-1 cells after 30 min of incubation, while MFI2- / -293T cells could not be endocytosed after 3 h of incubation, indicating that the nucleic acid aptamer MS2-1 can specifically Sexually binds and is endocyt...

Embodiment 3

[0019] Example 3: The coupling of aptamer MS2-1 and doxorubicin specifically inhibits the proliferation of MFI2-positive pancreatic cancer cells.

[0020] NB4 cells and Panc-1 cells were planted in a 96-well plate, with 10,000 cells per well, and 10ul of different concentrations of aptamer MS2 and doxorubicin-coupled drug MS2-1-Dox or doxorubicin single drug was added, After incubation for 72 hours, 20 ul of MTT with a concentration of 5 mg / ml was added, 100 ul of triple solution was added after 4 hours, and the absorbance was detected at a wavelength of 595 nm after incubation for 16 hours.

[0021] The results showed that MS2-1-Dox, the conjugated drug of nucleic acid aptamer MS2-1 and doxorubicin, could specifically inhibit the proliferation of MFI2+ / +Panc-1 cells, while for MFI2- / - NB4 cells, the conjugated drug could not inhibit its proliferation, but could significantly reduce the toxicity of doxorubicin, indicating that the conjugated drug MS2-1-Dox can specifically de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a nucleic acid aptamer targeting cell surface antigen MFI2 protein and its application, the sequence of which is shown in SEQ NO.1. The present invention screens the aptamer targeting the cell surface antigen MFI2 protein from the ssDNA library by means of cell screening, and analyzes the sequences in the screened library by means of high-throughput sequencing, and finally through the analysis of the obtained sequences Based on the analysis of stability and affinity, the aptamer MS2‑1 was selected. And the method of flow cytometry and immunofluorescence proves that the aptamer MS2-1 can specifically target MFI2-positive tumor cells and enter the cells through endocytosis. It can be used in the preparation of pancreatic cancer targeted therapy drugs or detection reagents.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, and specifically relates to a nucleic acid aptamer targeting cell surface antigen MFI2 protein and its application. Background technique [0002] Pancreatic cancer is considered to be one of the malignant tumors with the highest mortality rate due to its difficulty in early diagnosis, poor late treatment effect, and easy local recurrence and distant metastasis. Molecular targeted therapy is considered to be an effective method for the treatment of pancreatic cancer because of its high specificity and high efficiency of killing tumor cells. In the previous study, we confirmed that the pancreatic cancer-specific membrane protein-Melanotransferrin (MFI2) is a highly sensitive, specific and structurally stable pancreatic New targets for cancer therapy. [0003] At present, most anti-tumor drugs have a good killing effect on tumor cells, but due to the lack of specific recognition ability for tumor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/115A61K47/54A61P35/00G01N33/574
CPCC12N15/115A61K47/549A61P35/00G01N33/57438C12N2310/16
Inventor 那仁满都拉杨畅王云洪德飞
Owner ZHEJIANG UNIV